<DOC>
	<DOCNO>NCT02692417</DOCNO>
	<brief_summary>Female sexual dysfunction , include sexual arousal disorder , significant clinical impact , affect million woman United States alone . Peripheral nerve stimulation , posterior tibial nerve stimulation ( PTNS ) dorsal genital nerve stimulation ( DGNS ) modulate neural circuit bladder fecal continence . The investigator hypothesize periodic DGNS PTNS modulate autonomic neural circuit promote improvement sexual function woman sexual arousal disorder . Subjects randomize receive one stimulation approach . Subjects weekly 30-minute session across twelve week .</brief_summary>
	<brief_title>Surface Stimulation Female Sexual Dysfunction</brief_title>
	<detailed_description />
	<criteria>Adult woman ≥ 18 year age Sexually active ≥ 1 time per month ( ≥ 2 time per month prefer ) Score 19 less 6question set Female Sexual Function Index ( FSFI ) survey Neurologically stable Ambulatory Capable give informed consent English speaking Capable willing follow study procedure Men Women ≤ 17 year age Pregnant planning get pregnant study period Clinically diagnose neurological bladder dysfunction Prior experience PTNS DGNS Current use transcutaneous electrical nerve stimulation ( TENS ) pelvis , back , leg Implanted pacemaker , defibrillator , spinal cord stimulator , sacral root stimulator Taking flibanserin Taking investigational drug History neurologic diseases impairment Any factor investigator feel would place patient increase risk study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>hypoactive desire disorder</keyword>
	<keyword>female sexual dysfunction</keyword>
	<keyword>genital arousal disorder</keyword>
	<keyword>sexual</keyword>
	<keyword>dysfunction</keyword>
	<keyword>female</keyword>
	<keyword>arousal</keyword>
	<keyword>electrical stimulation</keyword>
	<keyword>transcutaneous electrical stimulation</keyword>
	<keyword>woman</keyword>
</DOC>